| Filed On | Filing |
|---|---|
| 26 Oct 2026 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more
EXECUTION VERSION Credit Agreement - West Pharma (2026) (Conformed Signatures for 8-K Filing)(24019362844.2) - 10/26/2026 3:26:03 PM Deal CUSIP Number: 95530RAH2 Revolver A: 95530RAJ8 Revolver B: 95530RAL3 Term A Facility: 95530RAK5 CRED... |
| 02 Oct 2026 |
Form 4: Haugen Janet Brutschea, Director
Granted 44 Phantom Stock Unit ($16.3K) |
| 15 Sep 2026 |
Form 4: Favorite Annette F, Sr. VP & Chief HR Officer
Received 2,500 shares by exercise or conversion ($224K) · Sold 2,500 shares ($863K) · Received 2,500 shares by exercise or conversion ($224K) · 3 more |
| 10 Sep 2026 |
Form 4: Lagarde Michel, Director
Granted 37,048 Stock Option (Right to Buy) · Granted 14,750 Rst. Stock Unit |
| 10 Sep 2026 |
Form 4: Favorite Annette F, Sr. VP & Chief HR Officer
Received 8,135 shares by exercise or conversion ($694K) · Sold 8,135 shares ($2.77M) |
| 10 Sep 2026 |
Form 3: Lagarde Michel, Director
Holds 7,850 shares of Common Stock |
| 12 Aug 2026 |
Form 4: McMahon Robert W., SVP & Chief Financial Officer
Received 7,149.205 shares by exercise or conversion · Gave up 3,109.19 shares to cover exercise price or tax ($1.09M) |
| 06 Aug 2026 | SCHEDULE 13G |
| 23 Jul 2026 | 10-Q |
| 23 Jul 2026 | 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 14 Jul 2026 | 8-K: Entry into a Material Definitive Agreement |
| 01 Jul 2026 |
Form 4: Haugen Janet Brutschea, Director
Granted 46 Phantom Stock Unit ($16.5K) |
| 01 Jun 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure |
| 20 May 2026 |
8-K/A: Material Cybersecurity Incidents
As previously disclosed in the Original Report, the Company determined on May 7, 2026 that the Company had experienced a material cybersecurity attack, in which certain data was exfiltrated by an unauthorized party and certain systems we... |
| 14 May 2026 |
Form 4: Campbell Shane Alden, SVP, Proprietary Segment
Received 769.588 shares by exercise or conversion · Gave up 219.256 shares to cover exercise price or tax ($68.4K) |
| 13 May 2026 | SD |
| 11 May 2026 | 8-K: Material Cybersecurity Incidents; Regulation FD Disclosure |
| 07 May 2026 | 144 |
| 06 May 2026 |
Form 4: Pucci Paolo, Director
Received 791 shares as a grant or award |
| 06 May 2026 |
Form 4: Michels Douglas A, Director
Received 791 shares as a grant or award |
Loading...
